Ysa Biotec Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Revenue Growth %
- Profit Growth 91.13%
- Ebitda 475.00%
- Net Worth -5.68%
- Total Assets 2.76%
About Ysa Biotec
Ysa Biotec Private Limited (YBPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 June 2015 (Nine years and eight months 3 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Yatindra Singh and Sangeeta Singh serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120MH2015PTC265862
- Company No.
265862
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2015
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Ysa Biotec Private Limited offer?
Ysa Biotec Private Limited offers a wide range of products and services, including Batteries & Charge Storage Devices, Battery Accessories, Cosmetics, Hair & Beauty Products, Hair Care Cosmetics.
Who are the key members and board of directors at Ysa Biotec?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yatindra Singh  | Managing Director | 22-Jun-2015 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sangeeta Singh | Director | 22-Jun-2015 | Current |
Financial Performance of Ysa Biotec.
Ysa Biotec Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 91.13% increase in profit. The company's net worth dipped by a decrease of 5.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ysa Biotec?
In 2018, Ysa Biotec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biolinx Labsolutions Private LimitedYatindra Singh is a mutual person
My Biotech Private LimitedYatindra Singh and Sangeeta Singh are mutual person
Vantageceo Advisory Private LimitedYatindra Singh and Sangeeta Singh are mutual person
- Makequick Bio Private Limited
Sangeeta Singh is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jan 2017 | Others | ₹5.00 M | Open |
How Many Employees Work at Ysa Biotec?
Unlock and access historical data on people associated with Ysa Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ysa Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ysa Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.